Stakeholders Argue Over Deadline For Marking Of Reprocessed Devices
This article was originally published in The Gray Sheet
Executive Summary
Senators Michael Enzi (R-Wyo.) and Edward Kennedy (D-Mass.) say FDA is misinterpreting deadlines for recently enacted device marking provisions